What’s New In Glaucoma?
Paul Petrakos, DO, MS
Justin Schweitzer, OD, FAAO
I. Paul Singh, MD
Sarah H. Van Tassel, MD
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
Kendall Moseley, MD
Kenneth G. Saag, MD
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
Marilyn Yuanxin Ma Bui, MD, PhD
Anne Vincent-Salomon, MD
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Hans Katzberg, MD
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Nicholas J. Silvestri, MD
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Ocular to Generalized MG: How and Why the Disease Evolves
Personalizing Care Within the RCC Treatment Paradigm
Eric Jonasch, MD
Brad McGregor, MD
Ulka Vaishampayan, MBBS
What’s New in Suprachoroidal MIGS?
What’s New With 3D Visualization in Glaucoma Surgery?
New Solutions for Optimizing IOP Control: A Case-Based Approach
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.